NCT03608007 X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement Status UNKNOWN Phase PHASE2
NCT03603652 NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung Status TERMINATED Phase NA
NCT03602079 Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene Status COMPLETED Phase PHASE1/PHASE2
NCT03597009 A Study of Nivolumab and Intrapleural Talimogene Laherparepvec for Malignant Pleural Effusion Status TERMINATED Phase PHASE1/PHASE2
NCT03585959 superDimension™ Navigation System Version 7.2 With Fluoroscopic Navigation Technology Status COMPLETED Phase NA
NCT03578185 Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy Status RECRUITING Phase N/A
NCT03575793 A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03574194 Methionine-Restricted Diet to Potentiate The Effects of Radiation Therapy Status TERMINATED Phase NA
NCT03571126 Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer Status UNKNOWN Phase PHASE4
NCT03570645 Comparison of the Duration of Ropivacaine Combined With Dexmedetomidine or Dexamethasone on Paravertebral Block Status COMPLETED Phase PHASE4
NCT03568799 4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Status UNKNOWN Phase NA
NCT03567642 A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03563976 Multiparametric Image Analysis and Correlation With Outcomes in Lung Cancer Screening and Early Stage Lung Cancer Status RECRUITING Phase N/A
NCT03562052 Lung Cancer Screening in a Population Exposed to Occupational Lung Carcinogens Status RECRUITING Phase N/A
NCT03560362 Postoperative Pain Control With Lipossomic Extended Release Bupivacaine Status UNKNOWN Phase PHASE1/PHASE2
NCT03556228 VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma Status RECRUITING Phase PHASE1/PHASE2
NCT03554473 M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers Status COMPLETED Phase PHASE1/PHASE2
NCT03551405 4D Cone Beam CT Reconstruction for Radiotherapy Via Motion Vector Optimization Status TERMINATED Phase N/A